Improving Psoriatic Arthritis Screening in Psoriasis
Part of Bones, joints & muscles, Skin clinical trials.
This study tests a new way to screen for psoriatic arthritis (a type of joint inflammation) in people with psoriasis. It looks at a tool called PEST and aims to improve early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe plaque psoriasis (skin plaques that are thick, red, or scaly).
- Based on your doctor's opinion, you are a candidate for biologic medications (advanced treatments).
- You are 18 years or older.
- You live in Canada.
- You have not been diagnosed with psoriatic arthritis or other inflammatory arthritis like rheumatoid arthritis.
- You have not taken biologic medications for psoriasis or other conditions in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study is looking at adults with skin psoriasis and collecting real-world information about their condition and experiences. It may help researchers better understand psoriasis and how it affects people, without giving a new treatment.
This study compares two “treat-to-target” strategies for psoriatic arthritis. One strategy uses imaging to guide treatment changes, and the other uses standard clinic assessments, to see which approach controls symptoms more effectively.
This study looks at how psoriatic arthritis affects daily life and how that relates to disease activity. It may help researchers better understand the condition and improve care.
This study tests targeted medications for people with active psoriatic arthritis (PsA) who have already tried 1 or 2 other advanced treatments without success or couldn't tolerate them. The goal is to see if these newer options can better control joint pain and skin symptoms.
This trial compares two drugs, apremilast and adalimumab, to see which is more effective for people with psoriatic arthritis who have not responded well to methotrexate. It focuses on joint pain, swelling, and skin symptoms.
This study looks at how well advanced treatments work for people with psoriatic arthritis, and whether results differ for sex and gender. You may be eligible if your psoriatic arthritis is active and you are planning to start an advanced treatment for symptoms in the joints and surrounding areas.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.